TGFβI and S100A4 are abnormally upregulated in HCC, promoting the progression of HCC by activating ferroptosis of HCC cells and inhibiting mitochondrial oxidative stress damage. This evidence concerns the gene S100A4 and hepatocellular carcinoma.